18F-Fluorocholine (FCH) versus 18F-Fluorodesoxyglucose (FDG) PET/CT for the detection of lesions in patients with multiple myeloma

2024-516682-36-00 Therapeutic exploratory (Phase II) Ongoing, recruitment ended

Start 15 Dec 2020 · Status Ongoing, recruitment ended · 1 EU/EEA countries · 3 sites

Overview

Sponsor-declared trial summary

Phase Therapeutic exploratory (Phase II)
Status Ongoing, recruitment ended
Participants planned 38
Countries 1
Sites 3

Patients diagnosed with multiple myeloma

Key facts

Sponsor
Centr Georges Francois Leclerc
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Immune System Diseases [C20]
Trial duration
15 Dec 2020 → ongoing
Decision date (initial)
2024-08-23
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2024-516682-36-00
EudraCT number
2019-003627-38
ClinicalTrials.gov
NCT04349358

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Patients diagnosed with multiple myeloma

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Centr Georges Francois Leclerc

Sponsor organisation
Centr Georges Francois Leclerc
Address
1 Rue Professeur Marion
City
Dijon
Postcode
21000
Country
France

Scientific contact point

Organisation
Centr Georges Francois Leclerc
Contact name
Dr Clément DROUET

Public contact point

Organisation
Centr Georges Francois Leclerc
Contact name
Dr Clément DROUET

Locations

1 EU/EEA country · 3 investigational sites

By country

CountryMS statusPlanned subjectsSites
France Ongoing, recruitment ended 38 3
Rest of world 0

Investigational sites

France

3 sites · Ongoing, recruitment ended
CHU Besancon
25, 3 Boulevard Alexander Fleming, Cs 81816, Besancon Cedex
Centr Georges Francois Leclerc
21, 1 Rue Professeur Marion, 21000, Dijon
Centre Hospitalier Universitaire De Dijon
21, 14 Rue Paul Gaffarel, 21000, Dijon

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
France 2020-12-15 2020-12-15 2023-02-08

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-07-24 France Acceptable
2024-08-20
2024-08-23